US initial public offerings delivered underwhelming results in 2025 as equity-market volatility and increasing scrutiny ...

Over the next 18 months, more than 48 Indian startups are set to enter the public markets. The list includes some of the ...

Baidu rises sharply as it prepares to list its artificial-intelligence chip unit, taking advantage of a frenzy of Chinese ...

Several Chinese companies that raised about HK$6.99 billion ($900 million) combined in IPOs rallied strongly on their Hong ...

SpaceX will reportedly begin hearing pitches from investment banks as it weighs a historic IPO that has the potential to make Elon Musk the world’s first trillionaire. The Musk-led rocket company will ...

The scale of a SpaceX IPO would be historic. Bloomberg reports the company is seeking to raise more than $30 billion at a valuation of roughly $1.5 trillion. That would nearly double estimates from ...

SpaceX executives are starting the process to select Wall Street bankers to advise it on its initial public offering, according to people familiar with the matter. Investment banks are scheduled to ...

More than 20 years after founding SpaceX, the record-breaking company that transformed the global space industry, Elon Musk is planning to take the enterprise public. Here is a look at what is ...

WASHINGTON — SpaceX’s chief financial officer has confirmed the company is considering an initial public offering as soon as next year to raise money for lunar and Mars missions as well as orbital ...

The year 2025 started off red hot for startups going public, and then things got complicated. Market froth, tariffs, and the longest government shutdown on record combined to throw cold water on the ...

SpaceX is planning to go public in mid-to-late 2026 and is looking to raise $30 billion at a valuation of around $1.5 trillion, according to a new report from Bloomberg News citing multiple ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Beverly biotech is working ...